Delivery Order SPE2DB24D1034-SPE2DB25FWEZ1
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,671.82 to AmerisourceBergen Drug Corp for RotaTeq Vaccine 2ML on August 19, 2025, with an ultimate completion date of August 20, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. The contract will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $2,746.10 to AmerisourceBergen Drug Corp for the supply of RotaTeq vaccine (2ML formulation) on August 22, 2025, with an ultimate completion date of August 25, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award status. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of RotaTeq vaccine (2ML) on September 10, 2025, with a ceiling value of $13,268.58. This firm fixed-price delivery order, which carries an ultimate completion date of September 11, 2025, represents a child contract under AmerisourceBergen's broader pharmaceutical supply agreement with DLA. The contract was competitively awarded with no set-aside designation and will be performed at the...
- The Defense Logistics Agency awarded a delivery order valued at $2,331.36 to AmerisourceBergen Drug Corp for RotaTeq vaccine (2 mL formulation) on August 25, 2025, with completion scheduled for August 26, 2025. This firm fixed-price, competitively awarded delivery order represents a continuation of the vendor's extensive pharmaceutical supply relationship with DLA's Medical Supply Chain. The award specifies performance at AmerisourceBergen's Conshohocken, Pennsylvania facility, the company's...
- The Defense Logistics Agency (DLA) awarded a $1,076.56 delivery order to AmerisourceBergen Drug Corp for RotaTeq vaccine (2mL) on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price contract utilized no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued against AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of RotaTeq vaccine (2mL formulation) valued at $10,655.80. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive award of the pharmaceutical product. The order is scheduled for ultimate completion on August 6, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $5,327.90 delivery order to AmerisourceBergen Drug Corp for RotaTeq vaccine (2mL) on August 15, 2025, with an ultimate completion date of August 18, 2025. This non-set-aside contract employs firm fixed-price terms and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support...
- The Defense Logistics Agency awarded a $3,126.67 delivery order to AmerisourceBergen Drug Corp for RotaTeq vaccine (2 mL) on September 16, 2025, with completion targeted for September 17, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The product will be delivered to the company's distribution facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $3,286.08 to AmerisourceBergen Drug Corp for the supply of RotaTeq vaccine in 2ML units. The contract, issued on August 29, 2025, with an ultimate completion date of September 2, 2025, operates under firm fixed pricing with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency (DLA) awarded a $4,150.39 delivery order to AmerisourceBergen Drug Corp for RotaTeq vaccine (2 mL) on August 1, 2025, with an ultimate completion date of August 4, 2025. The contract utilizes firm fixed price pricing and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child...
- SPE2DB24D1034Indefinite Delivery Contract
- SPE2DB24D1034-SPE2DB25FWEZ1Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $17,117.66 to AmerisourceBergen Drug Corp for RotaTeq Vaccine (2ML) on August 12, 2025, with an ultimate completion date of August 13, 2025. This competitively awarded, firm fixed-price delivery order represents a single transaction under the company's larger pharmaceutical supply contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and healthcare solutions provider serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a vast range of pharmaceutical products and medical supplies, including specialty medications, vaccines, and related healthcare commodities to support military healthcare programs worldwide. The contract supports multiple federal customers including the Defense Health Agency and U.S. Coast Guard, reflecting the critical role of pharmaceutical distribution in maintaining military readiness and healthcare delivery.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.1k | 8/12/25 |